Tools · Private company · New Haven, CT, US
L2 Diagnostics, LLC
Track this companyFree. Adds L2 Diagnostics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- A novel therapeutic, L2ASOCLE, for treating cutaneous lupus erythematosus (CLE)Fiscal year 2026 · $323.1KNIH RePORTER 1R41AR087258-01A1 · fetched Nov 12, 2026
- PfAg, a multivalent peptide vaccine against malariaFiscal year 2026 · $300KNIH RePORTER 5R41AI195230-02 · fetched Nov 12, 2026
- A vaccine targeting mosquito metabolic pathways to eradicate malariaFiscal year 2026 · $300.1KNIH RePORTER 5R41AI195232-02 · fetched Nov 12, 2026
- A Point of Care Test for Babesia microtiFiscal year 2026 · $274.7KNIH RePORTER 5R43AI188960-02 · fetched Nov 12, 2026
- A viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus in a tick transmission modelFiscal year 2025 · $281.8KNIH RePORTER 1R41AI188982-01A1 · fetched Nov 12, 2026
- PfAg, a multivalent peptide vaccine against malariaFiscal year 2025 · $300KNIH RePORTER 1R41AI195230-01 · fetched Nov 12, 2026
- A vaccine targeting mosquito metabolic pathways to eradicate malariaFiscal year 2025 · $299.6KNIH RePORTER 1R41AI195232-01 · fetched Nov 12, 2026
- A Point of Care Test for Babesia microtiFiscal year 2025 · $293.1KNIH RePORTER 1R43AI188960-01 · fetched Nov 12, 2026
- A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogensFiscal year 2025 · $299.3KNIH RePORTER 5R41AI179587-02 · fetched Nov 12, 2026
- Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patchesFiscal year 2025 · $299.9KNIH RePORTER 5R41AI184218-02 · fetched Nov 12, 2026